28/04/2026

Successful completion of a GDP compliance audit for Falekas Transport’s Germany operations. Ensuring full alignment with pharmaceutical transport and quality requirements.

Successful GDP Audit for Falekas Transport Germany Branch

At Falekas Transport & Logistics, we are pleased to announce that our Germany branch successfully completed a GDP compliance audit on April 28, 2026, confirming full alignment with the European Union’s Good Distribution Practice (GDP) guidelines for the transport of pharmaceutical products.

The audit was conducted on behalf of a globally recognized logistics organization, known for its extensive international network and highly demanding quality and compliance standards within pharmaceutical supply chains. The evaluation covered our operational procedures, infrastructure, and quality systems, ensuring that all aspects of our pharmaceutical transport services meet strict regulatory and industry requirements.

Commitment to Pharmaceutical Quality & Compliance

Successfully passing this audit demonstrates our ability to operate under:

  • Strict GDP-compliant procedures and documentation
  • Controlled transport environments for temperature-sensitive products
  • Full traceability and operational transparency
  • Consistent application of quality and risk management protocols

Our GDP-compliant fleet, trained personnel, and advanced monitoring systems ensure that pharmaceutical products are transported under optimal conditions, safeguarding product integrity and patient safety throughout the entire logistics process.

This achievement further reinforces Falekas Transport & Logistics as a reliable partner in pharmaceutical and healthcare logistics, capable of meeting the expectations of globally operating organizations and complex supply chain environments.

It also reflects our ongoing investment in infrastructure, technology, and people, as well as our commitment to continuous improvement and adherence to the highest international standards.